May 23: Difference between revisions
Jump to navigation
Jump to search
FEisenberg (talk | contribs) New page: == May 23 QRPH Face-to-Face Meeting Minutes == Pending |
FEisenberg (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
== May 23 QRPH Face-to-Face Meeting Minutes == | == May 23 QRPH Face-to-Face Meeting Minutes == | ||
Attendees: | |||
Floyd Eisenberg (Siemens) | |||
Jason Colquit (Greenway Medical Systems) | |||
Sheila Teasdale (AMA) | |||
Delane Heldt (AMA) | |||
Harry Solomon (GE) | |||
Patty Craig (Joint Commission) | |||
Jan Orton (Intermountain Healthcare) | |||
Randolph Barrows (MedAllies) | |||
Daemon Whittenberg (Greenway Medical Systems) | |||
Joann Larson (Kaiser) | |||
Ana Estelrich (GMP-DIP) | |||
Chris Carr (RSNA) | |||
# Clinical Research Profile | |||
##“Other option” requires review – Send to QRPH TC – Schedule one call | |||
# Drug Safety Profile | |||
## Pull content from Clinical Research Profile | |||
## E2B describes data elements | |||
### How to describe what was the adverse event | |||
### Need to identify the information to be send and how based on the trigger | |||
## Calls | |||
## At risk June 9 | |||
# White paper | |||
## Requires 2 calls | |||
Revision as of 12:07, 23 May 2008
May 23 QRPH Face-to-Face Meeting Minutes
Attendees: Floyd Eisenberg (Siemens) Jason Colquit (Greenway Medical Systems) Sheila Teasdale (AMA) Delane Heldt (AMA) Harry Solomon (GE) Patty Craig (Joint Commission) Jan Orton (Intermountain Healthcare) Randolph Barrows (MedAllies) Daemon Whittenberg (Greenway Medical Systems) Joann Larson (Kaiser) Ana Estelrich (GMP-DIP) Chris Carr (RSNA)
- Clinical Research Profile
- “Other option” requires review – Send to QRPH TC – Schedule one call
- Drug Safety Profile
- Pull content from Clinical Research Profile
- E2B describes data elements
- How to describe what was the adverse event
- Need to identify the information to be send and how based on the trigger
- Calls
- At risk June 9
- White paper
- Requires 2 calls